Clinical Trials in Michigan

Showing 5541-5560 of 16,154 trials

Genomics in Michigan Impacting Observation or Radiation

NCT02783950

To determine the impact of Decipher test results on adjuvant treatment decisions of high-risk post-RP patients with undetectable post-op prostate specific antigen (PSA) compared to clinical factors alone.

Prostate Cancer

University of Michigan Rogel Cancer Center356 participantsStarted Jan 2017

Ann Arbor, Michigan, United States • Detroit, Michigan, United States • Detroit, Michigan, United States +10 more locations

COMPLETEDPhase 362 miles

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

NCT03201757

This study will evaluate the long-term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder

SchizophreniaSchizophreniform DisorderBipolar I Disorder

Alkermes, Inc.523 participantsStarted Jun 2017

Little Rock, Arkansas, United States • Rogers, Arkansas, United States • Anaheim, California, United States +82 more locations

Genomics in Michigan Impacting Observation or Radiation

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

Find Trials by Condition in Michigan

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Safety and Performance of PEEK Anchors in Extremities

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

Open-Label Extension Study of Trofinetide for Rett Syndrome

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

BALANCE+ Vanguard Phase

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.